N-[2-[4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]-2-(trifluoromethyl)pyrimidine-5-carboxamide
C23H26F3N5O3 — CID 155437655
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]-2-(trifluoromethyl)pyrimidine-5-carboxamide
N-[2-[4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]-2-(trifluoromethyl)pyrimidine-5-carboxamide (PubChem CID 155437655) has the molecular formula C23H26F3N5O3 and a molecular weight of 477.49 g/mol. Its IUPAC name is N-[2-[4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]-2-(trifluoromethyl)pyrimidine-5-carboxamide.
Molecular Properties
| Compound Name | N-[2-[4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]-2-(trifluoromethyl)pyrimidine-5-carboxamide |
|---|---|
| PubChem CID | 155437655 |
| Molecular Formula | C23H26F3N5O3 |
| Molecular Weight | 477.49 g/mol |
| Exact Mass | 477.20 |
| IUPAC Name | N-[2-[4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)indazol-5-yl]-2-(trifluoromethyl)pyrimidine-5-carboxamide |
| SMILES | CC(C)(O)c1cc2nn(C3CCC(CO)CC3)cc2cc1NC(=O)c1cnc(C(F)(F)F)nc1 |
| InChI | InChI=1S/C23H26F3N5O3/c1-22(2,34)17-8-18-14(11-31(30-18)16-5-3-13(12-32)4-6-16)7-19(17)29-20(33)15-9-27-21(28-10-15)23(24,25)26/h7-11,13,16,32,34H,3-6,12H2,1-2H3,(H,29,33) |
| InChIKey | SJCLMSSVMACEPL-UHFFFAOYSA-N |
| XLogP | 4.05 |
| TPSA | 113.16 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 477.49 |
| LogP ≤ 5 | 4.05 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155437655 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.